Inhibitory effect of ethyl acetate extract of the shaggy inc cap medicinal mushroom, Coprinus comatus (Higher Basidiomycetes) fruit bodies on cell growth of human ovarian cancer.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  International Journal of Medicinal Mushrooms

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1615/INTJMEDMUSHR.V15.I5.40PMID 24266371
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of culinary-medicinal mushrooms on human welfare with a pyramid model for human health.

  2012cited by this paper
• The Shaggy Inc Cap medicinal mushroom, Coprinus comatus (O.F.Mull.: Fr.) Pers. (Agaricomycetideae) substances interfere with H2O2 induction of the NF-kappaB pathway through inhibition of Ikappaalpha phosphorylation in MCF7 breast cancer cells.

  2011cited by this paper
• The Culinary-Medicinal Mushroom Coprinus comatus as a Natural Antiandrogenic Modulator

  2011cited by this paper
• Separation of an aqueous extract Inonotus obliquus (Chaga). A novel look at the efficiency of its influence on proliferation of A549 human lung carcinoma cells.

  2010cited by this paper
• Antioxidant Properties of Cap and Stipe from Coprinus comatus

  2010cited by this paper
• MicroRNAs in ovarian cancer biology and therapy resistance.

  2010cited by this paper
• Comparison of Hypoglycemic Activity of Trace Elements Absorbed in Fermented Mushroom of Coprinus comatus

  2009cited by this paper
• Cytotoxic Components of Pereskia bleo (Kunth) DC. (Cactaceae) Leaves

  2009cited by this paper
• Coprinus comatus and Ganoderma lucidum interfere with androgen receptor function in LNCaP prostate cancer cells

  2008cited by this paper
• Jaceosidin Induces Apoptosis in Human Ovary Cancer Cells through Mitochondrial Pathway

  2008cited by this paper
• A novel indole ethyl isothiocyanate (7Me-IEITC) with anti-proliferative and pro-apoptotic effects on platinum-resistant human ovarian cancer cells.

  2008cited by this paper
• Cell death modalities: classification and pathophysiological implications

  2007cited by this paper
• Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study

  2007cited by this paper
• Fungal substances as modulators of NF-kappaB activation pathway.

  2007cited by this paper
• Prevention of ovarian cancer.

  2006cited by this paper
• Structural elucidation of a neutral fucogalactan from the mycelium of Coprinus comatus.

  2006cited by this paper
• In vitro effects on proliferation, apoptosis and colony inhibition in ER-dependent and ER-independent human breast cancer cells by selected mushroom species.

  2006cited by this paper
• Inhibition of Growth and Induction of Apoptosis in Human Cancer Cell Lines by an Ethyl Acetate Fraction from Shiitake Mushrooms

  2006cited by this paper
• Quantitative determination of six major triterpenoids in Ganoderma lucidum and related species by high performance liquid chromatography.

  2006cited by this paper
• Antiproliferative and apoptotic effects of zinc-citrate compound (CIZAR(R)) on human epithelial ovarian cancer cell line, OVCAR-3.

  2006cited by this paper
• Treatments for gynaecological cancers.

  2006cited by this paper
• Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009

  2005cited by this paper
• Selective induction of apoptosis in murine skin carcinoma cells (CH72) by an ethanol extract of Lentinula edodes.

  2005cited by this paper
• Medicinal mushroom modulators of molecular targets as cancer therapeutics

  2005cited by this paper
• Immunomodulating and anti-tumor action of extracts of several mushrooms.

  2004cited by this paper
• Cell cycle and apoptotic proteins in relation to ovarian epithelial morphology.

  2004cited by this paper
• Body size and ovarian cancer: case–control study and systematic review (Australia)

  2004cited by this paper
• Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation.

  2003cited by this paper
• Fatigue in ovarian carcinoma patients

  2003cited by this paper
• Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups.

  2003cited by this paper
• Cyclooxygenase inhibitory and antioxidant compounds from the mycelia of the edible mushroom Grifola frondosa.

  2002cited by this paper
• Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides

  2002cited by this paper
• Epidemiological and molecular aspects of ovarian cancer risk

  2001cited by this paper
• Antiproliferative mechanism of retinoid derivatives in ovarian cancer cells.

  2001cited by this paper
• Suillusin, a unique benzofuran from the mushroom Suillus granulatus.

  2001cited by this paper
• Quality of life and mood in women receiving extensive chemotherapy for gynecologic cancer

  2000cited by this paper
• Treatment modality affects long-term quality of life in gynaecological cancer.

  2000cited by this paper
• p53 mutations and expression in ovarian cancers: correlation with overall survival.

  1999cited by this paper
• Selective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete, Agaricus blazei Murill, mediated via natural killer cell activation and apoptosis

  1998cited by this paper
• Dietary fat intake and risk of epithelial ovarian cancer.

  1994cited by this paper
• Activation of peritoneal macrophages in patients with gynecological malignancies by sizofiran and recombinant interferon-γ

  1993cited by this paper
• Improvement of long-term prognosis in patients with ovarian cancers by adjuvant sizofiran immunotherapy: a prospective randomized controlled study

  1993cited by this paper
• Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group.

  1992cited by this paper
• Interferon-alpha, interferon-gamma and sizofiran in the adjuvant therapy in ovarian cancer--a preliminary trial.

  1992cited by this paper
• Malignant transformation of ovarian epithelium.

  1992cited by this paper
• Dietary factors and epithelial ovarian cancer.

  1989cited by this paper
• Association of obesity and ovarian cancer in a case-control study.

  1989cited by this paper

• Mushrooms as potential therapeutic agents in the treatment of cancer: Evaluation of anti-glioma effects of Coprinus comatus, Cantharellus cibarius, Lycoperdon perlatum and Lactarius deliciosus extracts.

  2021cites this paper
• The two faces of Coprinus comatus—Functional properties and potential hazards

  2020cites this paper
• Comparative study on the monosaccharide compositions, antioxidant and hypoglycemic activities in vitro of intracellular and extracellular polysaccharides of liquid fermented Coprinus comatus.

  2019cites this paper
• Epidemiology of Ovarian Cancer: Risk Factors and Prevention

  2018cites this paper
• Between the Bioactive Extracts of Edible Mushrooms and Pharmacologically Important Nanoparticles: Need for the Investigation of a Synergistic Combination- A Mini Review

  2017cites this paper
• Evaluation of the Antioxidant Activities and Tyrosinase Inhibitory Property from Mycelium Culture Extracts

  2015cites this paper
• The Shaggy Ink Cap Medicinal Mushroom, Coprinus comatus (Higher Basidiomycetes) Extract Induces Apoptosis in Ovarian Cancer Cells via Extrinsic and Intrinsic Apoptotic Pathways.

  2015cites this paper
• The biotechnology of higher fungi-current state and perspectives

  2014cites this paper
• The biotechnology of higher fungi - current state and perspectives

  2014cites this paper
• A Novel Laccase with Potent Antiproliferative and HIV-1 Reverse Transcriptase Inhibitory Activities from Mycelia of Mushroom Coprinus comatus

  2014cites this paper